BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32442047)

  • 1. Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts.
    Oda S; Kidoh M; Nagayama Y; Takashio S; Usuku H; Ueda M; Yamashita T; Ando Y; Tsujita K; Yamashita Y
    Radiographics; 2020; 40(4):961-981. PubMed ID: 32442047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in diagnosis and treatment of cardiac amyloidosis.
    Izumiya Y; Takashio S; Oda S; Yamashita Y; Tsujita K
    J Cardiol; 2018 Feb; 71(2):135-143. PubMed ID: 29113705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
    Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
    Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis.
    Addison D; Slivnick JA; Campbell CM; Vallakati A; Jneid H; Schelbert E
    J Am Heart Assoc; 2021 May; 10(9):e019840. PubMed ID: 33899502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cardiac MR Imaging in the Assessment of Patients with Cardiac Amyloidosis.
    Carvalho FP; Erthal F; Azevedo CF
    Magn Reson Imaging Clin N Am; 2019 Aug; 27(3):453-463. PubMed ID: 31279449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.
    Khor YM; Cuddy S; Falk RH; Dorbala S
    Semin Nucl Med; 2020 Jul; 50(4):295-310. PubMed ID: 32540027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
    White JA; Fine NM
    Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advance of echocardiography in cardiac amyloidosis.
    Liang S; Liu Z; Li Q; He W; Huang H
    Heart Fail Rev; 2023 Nov; 28(6):1345-1356. PubMed ID: 37558934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic evaluation of cardiac amyloid.
    Tsang W; Lang RM
    Curr Cardiol Rep; 2010 May; 12(3):272-6. PubMed ID: 20424972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging.
    Legou F; Tacher V; Damy T; Planté-Bordeneuve V; Rappeneau S; Benhaiem N; Rosso J; Itti E; Luciani A; Kobeiter H; Rahmouni A; Deux JF
    Diagn Interv Imaging; 2017 Feb; 98(2):125-132. PubMed ID: 27692958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging findings of right cardiac amyloidosis: impact on prognosis and clinical course.
    Tana M; Tana C; Palmiero G; Mantini C; Coppola MG; Limongelli G; Schiavone C; Porreca E
    J Ultrasound; 2023 Sep; 26(3):605-614. PubMed ID: 37162729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis.
    Liu D; Niemann M; Hu K; Herrmann S; Störk S; Knop S; Ertl G; Weidemann F
    Am J Cardiol; 2011 Aug; 108(4):591-8. PubMed ID: 21807135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 3D and speckle tracking echocardiography in cardiac amyloidosis: a case report.
    Nucci EM; Lisi M; Cameli M; Baldi L; Puccetti L; Mondillo S; Favilli R; Lunghetti S
    Eur Rev Med Pharmacol Sci; 2014; 18(1):74-7. PubMed ID: 24452946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report].
    Povar Echeverría M; Auquilla Clavijo PE; Escobedo Palau JA; Navarro Beltrán P; Povar Marco J
    An Sist Sanit Navar; 2018 Aug; 41(2):263-267. PubMed ID: 29943762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis.
    Porciani MC; Lilli A; Perfetto F; Cappelli F; Massimiliano Rao C; Del Pace S; Ciaccheri M; Castelli G; Tarquini R; Romagnani L; Pastorini T; Padeletti L; Bergesio F
    Amyloid; 2009; 16(2):63-70. PubMed ID: 20536397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.